Dose Escalation Impacts Biochemical Outcomes of Inadequate PSA Nadir During Neoadjuvant Hormone Therapy Before Brachytherapy for Intermediate-Risk Prostate Cancer

Authors :: Tsutomu Tanaka
Kayo Yoshida
Yutaka Shiraishi
Atsunori Yorozu
A. Takahashi
N. Kuroiwa
Toshio Ohashi
Shiro Saito
Kazuhito Toya
Source :: International Journal of Radiation Oncology*Biology*Physics. 87:S352-S353
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
medicine.medical_treatment
Brachytherapy
medicine.disease
Prostate cancer
Internal medicine
medicine
Dose escalation
Radiology, Nuclear Medicine and imaging
Hormone therapy
Intermediate risk
business
Psa nadir

Tools